Luteal Phase Deficiency (LPD)

By RRM Academy Reviewed by Dr. Naomi Whittaker, MD, Board-Certified OBGYN, MIGS, NFPMC, FCI Updated May 13, 2026

Luteal Phase Deficiency (LPD) is a hormonal condition in which the corpus luteum produces insufficient progesterone, the luteal phase is too short, or the endometrium fails to respond adequately to progesterone, impairing implantation and early pregnancy support. The most common causes are impaired follicular development leading to an under-capable corpus luteum, hypothyroidism, hyperprolactinemia, and disrupted GnRH pulsatility. The NaPro post-Peak duration threshold for a short luteal phase is 8 days, not the older 11-day BBT-phase criterion from the Vollman/Jones era. These measured different endpoints with different methods.¹²

In RRM practice, LPD is diagnosed from cycle-timed progesterone measurements anchored to the Peak Day. The Peak+3 progesterone level confirms ovulation and establishes early luteal function. A result of 2.3 ng/mL or above confirms ovulation has occurred. A result of 3.0 ng/mL or above indicates an absolute period of postovulation infertility has begun. Values below these thresholds warrant evaluation before further cycle-timed treatment.³ The Peak+3 through Peak+11 series provides the integrated hormonal picture. See Sonographic Ovulation Classification for ultrasound correlates used alongside progesterone values to characterize ovulation quality.

Hilgers identified five distinct LPD subtypes, each with a different mechanism and treatment target.⁴ Type I combines a short post-Peak phase with low end-luteal progesterone. Type II shows normal duration but suboptimal integrated progesterone output. Type III is a late-drop pattern in which progesterone collapses 50% or more relative to peak luteal value before the phase ends. Type IV presents as an early-luteal deficit where progesterone fails to rise adequately from Peak+3. Type V is an isolated luteal estradiol deficit; see Cooperative Estrogen Replacement Therapy (CERT) and Cooperative Progesterone Replacement Therapy (CPRT) for the relevant hormonal support approaches. When the deficit originates specifically from inadequate corpus luteum output, see Corpus Luteum Deficiency (CLD). LPD is treatable. Accurate cycle charting combined with targeted hormonal evaluation identifies the subtype and directs the corrective approach.

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.